Skip to main content
Clinical Trials/TCTR20180224001
TCTR20180224001
Recruiting
Phase 4

The Predictability of Bleeding on Patient Taking Warfarin by Machine Learning Method

Faculty of Pharmacy, Silpakorn University0 sites300 target enrollmentFebruary 24, 2018

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
patient taking warfarin over 6 monthsAge 18 or older
Sponsor
Faculty of Pharmacy, Silpakorn University
Enrollment
300
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 24, 2018
End Date
November 30, 2018
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Faculty of Pharmacy, Silpakorn University

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients taking warfarin and older than 18 years old
  • 2\) Patients treated with warfarin over 6 months
  • 3\) Patients agree to participate in the study by signing the consent form
  • 4\) Patients can use Thai language to communicate

Exclusion Criteria

  • 1\) Patients refused to attend the study
  • 2\) Patients with hearing impairment
  • 3\) Patients with memory impairment
  • 4\) Patients with incomplete medical records

Outcomes

Primary Outcomes

Not specified

Similar Trials